SlideShare una empresa de Scribd logo
1 de 14
Tobacco Control & Prevention
      National Update


 Presented to Tobacco Program Grant
         Review Committee
            Dec. 16, 2011
Major Initiatives
• Centers for Disease Control and
  Prevention
   –Office on Smoking & Health
• U.S. Food & Drug Administration
  (FDA)
• National Tobacco Control Strategy
• Health Care Reform
CDC – Office on Smoking & Health
• “Accelerating the Decline” initiative
   – Perception problem is solved, lack of advocacy
     partners, 18-24 yrs. & low SES still high, better use
     FDA authority.
• Upcoming Surgeon General’s Report on Youth
  Tobacco Use – (Spring 2012)
• First ever national media campaign
   – Spring of 2012, hard hitting, 1-800 Quitline number
• Less than .02 per dollar of revenue going towards
  programs – big reductions in states
• Federal funding cuts, OSH competitive grant?
U.S. Food and Drug Administration
• Granted Regulatory Authority over tobacco
  products (6/09)
• Restricts Marketing and Sales to Youth
• Requires Disclosure of Ingredients
• Regulates “reduces harm” claims (no more light,
  mild, or low-tar)
• Bigger, bolder health warnings on packages
• Requires industry to pay user fee to FDA to
  support efforts ($800M/yr)
U.S. Food and Drug Administration
• Authority to further restrict marketing
• Allows FDA to require changes in the product
  (cannot ban nicotine completely)
• Created the Tobacco Products Scientific
  Advisory Committee (TPSAC)
  – Recommended removal of menthol cigarettes
    from the market)
  – Working on dissolvable tobacco products (3/12)
U.S. Food and Drug Administration
• Industry preventing progress by:
   –Suing over warning labels
   –Suing over Menthol report
   – Increasing marketing and sales of
    dissolvable tobacco products
   –Suing some more about anything
National Tobacco Prevention and
            Control Strategy
• First of its kind comprehensive national plan
• “Ending the Tobacco Epidemic” –Released by
  HHS – Nov. 2010
• Focused on Evidenced- based strategies
• Includes national media campaign
• Requires all HHS campuses are tobacco free
• Required Medicare and Medicaid to include
  tobacco cessation services
• Includes more funding for research
Health Care Reform
• New Coverage Under Medicaid
  – Oct. 1, 2010 – state Medicaid programs must provide
    a comprehensive cessation benefit with no-cost
    sharing/co-pay & requires expanded private insurance
    coverage of cessation/treatment without cost sharing
  – Jan. 1, 2013 – increased federal reimbursements for
    cessation
  – Jan 1, 2014 – state Medicaid programs cannot exclude
    smoking cessation drugs form their prescription drug
    coverage
Health Care Reform
• Creation of Public Health Prevention Fund to
  support proven prevention, wellness and
  public health programs in communities
  – Community Transformation Grants that include
    additional funding for tobacco programs &
    QuitLines
  – Possible 68% cut to offset impact of continued
    payroll tax deductions (changes by the day)
Key Opportunities
• National media campaign with quit smoking call
  to action & QuitLine # (spring 2012)
• Warning labels with QuitLine # (fall 2013)
• Banning of Menthol ??
• Release of Surgeon Generals report on Youth
  Tobacco Use (Spring 2012)
• Insurance Reimbursement for cessation services
  and counseling
• FDA – needs for input, testimony from states
Key Threats
• Modified Risk Products
• Dissolvable Tobacco Products
• Stall in decreases of adult prevalence
• Increases in use among 18-24 year olds
• Competitive applications for CDC funds
• Tobacco issues is solved – obesity is the
  problem
• Low SES smokers – how to get them to quit
Always the Question
• DOES SPENDING MORE ON
  TOBACCO CONTROL PROGRAMS
  MAKE ECONOMIC SENSE?
AN INCREMENTAL BENEFIT-COST ANALYSIS USING PANEL DATA
  Journal of Contemporary Economic Policy, Nov. 27. 2011


• This paper presents a benefit-cost analysis of the ongoing,
  state-level tobacco prevention and control programs in the
  United States. Using state-level panel data for the years
  1991–2007, the study applies several variants of
  econometric modeling approaches to estimate the state-
  level tobacco demand. The paper finds a statistically
  significant evidence of a sustained and steadily increasing
  long-run impact of the tobacco control program spending
  on cigarette demand in states. The study also shows that, if
  individual states follow the Best Practices funding
  guidelines, potential future annual benefits of the tobacco
  control program can be as high as 14–20 times the cost of
  program implementation. (JEL C2, H5, I1)
Questions
& Discussion

Más contenido relacionado

La actualidad más candente

News Flash November 11, 2013 - Final Mental Health Parity Regulations Issued
News Flash November 11, 2013 - Final Mental Health Parity Regulations IssuedNews Flash November 11, 2013 - Final Mental Health Parity Regulations Issued
News Flash November 11, 2013 - Final Mental Health Parity Regulations IssuedAnnette Wright, GBA, GBDS
 
What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?Canadian Cancer Survivor Network
 
Medicines Transparency in Jordan
Medicines Transparency in JordanMedicines Transparency in Jordan
Medicines Transparency in JordanMeTApresents
 
Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?
Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?
Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?Canadian Organization for Rare Disorders
 
July 30 Webinar 3: Sharing and comparing feedback for the PMPRB Guidelines
July 30 Webinar 3: Sharing and comparing feedback for the PMPRB GuidelinesJuly 30 Webinar 3: Sharing and comparing feedback for the PMPRB Guidelines
July 30 Webinar 3: Sharing and comparing feedback for the PMPRB GuidelinesCanadian Organization for Rare Disorders
 
How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...Canadian Cancer Survivor Network
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015yahyasultan
 
Typical Cost Containment Policies during Economic Stagnation
Typical Cost Containment Policies during Economic StagnationTypical Cost Containment Policies during Economic Stagnation
Typical Cost Containment Policies during Economic StagnationRuby Med Plus
 
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017Canadian Organization for Rare Disorders
 
Rx15 vision wed_200_oig
Rx15 vision wed_200_oigRx15 vision wed_200_oig
Rx15 vision wed_200_oigOPUNITE
 
Wed vs ondcp labelle
Wed vs ondcp labelleWed vs ondcp labelle
Wed vs ondcp labelleOPUNITE
 

La actualidad más candente (20)

News Flash November 11, 2013 - Final Mental Health Parity Regulations Issued
News Flash November 11, 2013 - Final Mental Health Parity Regulations IssuedNews Flash November 11, 2013 - Final Mental Health Parity Regulations Issued
News Flash November 11, 2013 - Final Mental Health Parity Regulations Issued
 
What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?What is patient engagement at CADTH, and how can you get involved?
What is patient engagement at CADTH, and how can you get involved?
 
Medicines Transparency in Jordan
Medicines Transparency in JordanMedicines Transparency in Jordan
Medicines Transparency in Jordan
 
Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?
Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?
Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?
 
Webinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% SolutionWebinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% Solution
 
July 30 Webinar 3: Sharing and comparing feedback for the PMPRB Guidelines
July 30 Webinar 3: Sharing and comparing feedback for the PMPRB GuidelinesJuly 30 Webinar 3: Sharing and comparing feedback for the PMPRB Guidelines
July 30 Webinar 3: Sharing and comparing feedback for the PMPRB Guidelines
 
Examining Models for a National Pharmacare Program
Examining Models for a National Pharmacare ProgramExamining Models for a National Pharmacare Program
Examining Models for a National Pharmacare Program
 
Sym 8c_TH Why and How?_8 Apr 2019
Sym 8c_TH Why and How?_8 Apr 2019Sym 8c_TH Why and How?_8 Apr 2019
Sym 8c_TH Why and How?_8 Apr 2019
 
Projected impact of demographic change on the demand for pharmaceuticals in I...
Projected impact of demographic change on the demand for pharmaceuticals in I...Projected impact of demographic change on the demand for pharmaceuticals in I...
Projected impact of demographic change on the demand for pharmaceuticals in I...
 
How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...How Canada's health technology assessment system can change to better meet pa...
How Canada's health technology assessment system can change to better meet pa...
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015
 
Typical Cost Containment Policies during Economic Stagnation
Typical Cost Containment Policies during Economic StagnationTypical Cost Containment Policies during Economic Stagnation
Typical Cost Containment Policies during Economic Stagnation
 
FMCC 2016 Health Is Primary by Robert Phillips
FMCC 2016 Health Is Primary by Robert PhillipsFMCC 2016 Health Is Primary by Robert Phillips
FMCC 2016 Health Is Primary by Robert Phillips
 
Refocus PMPRB “Back to the Future”: Part One.
Refocus PMPRB “Back to the Future”: Part One.Refocus PMPRB “Back to the Future”: Part One.
Refocus PMPRB “Back to the Future”: Part One.
 
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
 
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
 
Rx15 vision wed_200_oig
Rx15 vision wed_200_oigRx15 vision wed_200_oig
Rx15 vision wed_200_oig
 
Health sectorreformdhs
Health sectorreformdhsHealth sectorreformdhs
Health sectorreformdhs
 
Wed vs ondcp labelle
Wed vs ondcp labelleWed vs ondcp labelle
Wed vs ondcp labelle
 
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
 

Destacado

LAAMPP Policy Webinar - Jeannette Noltenius
LAAMPP Policy Webinar - Jeannette NolteniusLAAMPP Policy Webinar - Jeannette Noltenius
LAAMPP Policy Webinar - Jeannette NolteniusLAAMPP
 
Smokeless tobacco and cotpa
Smokeless tobacco and cotpaSmokeless tobacco and cotpa
Smokeless tobacco and cotpaWal
 
Control of tobacco products act
Control of tobacco products actControl of tobacco products act
Control of tobacco products actManjari Reshikesh
 
National tobacco control program (ntcp)
National tobacco control program (ntcp)National tobacco control program (ntcp)
National tobacco control program (ntcp)sarahg326
 
Tobacco/Nicotine presentation
Tobacco/Nicotine presentation Tobacco/Nicotine presentation
Tobacco/Nicotine presentation cmariorenzi
 
Nicotine addiction
Nicotine addictionNicotine addiction
Nicotine addictionvelspharmd
 
Applicant webinar tobacco community initiatives
Applicant webinar tobacco community initiativesApplicant webinar tobacco community initiatives
Applicant webinar tobacco community initiativesBrandon Williams
 
Ccpd stakeholder input process 01 13-12
Ccpd stakeholder input process 01 13-12Ccpd stakeholder input process 01 13-12
Ccpd stakeholder input process 01 13-12Brandon Williams
 
SugarCRM Project Management Enhancements
SugarCRM Project Management EnhancementsSugarCRM Project Management Enhancements
SugarCRM Project Management EnhancementsAtcore Systems
 

Destacado (20)

LAAMPP Policy Webinar - Jeannette Noltenius
LAAMPP Policy Webinar - Jeannette NolteniusLAAMPP Policy Webinar - Jeannette Noltenius
LAAMPP Policy Webinar - Jeannette Noltenius
 
National Tobacco Control Strategy (NTCS)
National Tobacco Control Strategy (NTCS)National Tobacco Control Strategy (NTCS)
National Tobacco Control Strategy (NTCS)
 
Smokeless tobacco and cotpa
Smokeless tobacco and cotpaSmokeless tobacco and cotpa
Smokeless tobacco and cotpa
 
Control of tobacco products act
Control of tobacco products actControl of tobacco products act
Control of tobacco products act
 
National tobacco control program (ntcp)
National tobacco control program (ntcp)National tobacco control program (ntcp)
National tobacco control program (ntcp)
 
Tobacco/Nicotine presentation
Tobacco/Nicotine presentation Tobacco/Nicotine presentation
Tobacco/Nicotine presentation
 
Cotpa 03
Cotpa 03Cotpa 03
Cotpa 03
 
Nicotine addiction
Nicotine addictionNicotine addiction
Nicotine addiction
 
Applicant webinar tobacco community initiatives
Applicant webinar tobacco community initiativesApplicant webinar tobacco community initiatives
Applicant webinar tobacco community initiatives
 
39 Trine Borake, Slaggegruben ved stude
39 Trine Borake, Slaggegruben ved stude39 Trine Borake, Slaggegruben ved stude
39 Trine Borake, Slaggegruben ved stude
 
Henrik Skousen skejby
Henrik Skousen skejbyHenrik Skousen skejby
Henrik Skousen skejby
 
Ccpd stakeholder input process 01 13-12
Ccpd stakeholder input process 01 13-12Ccpd stakeholder input process 01 13-12
Ccpd stakeholder input process 01 13-12
 
Nick Wintherbotham, Learning across frontiers
Nick Wintherbotham, Learning across frontiersNick Wintherbotham, Learning across frontiers
Nick Wintherbotham, Learning across frontiers
 
Martin Egelund Poulsen, kongehøj iii langhuse og stenfyldte forsænkninger fra...
Martin Egelund Poulsen, kongehøj iii langhuse og stenfyldte forsænkninger fra...Martin Egelund Poulsen, kongehøj iii langhuse og stenfyldte forsænkninger fra...
Martin Egelund Poulsen, kongehøj iii langhuse og stenfyldte forsænkninger fra...
 
Peter Vang Petersen, Danefæ 2012
Peter Vang Petersen, Danefæ 2012Peter Vang Petersen, Danefæ 2012
Peter Vang Petersen, Danefæ 2012
 
28 kirsten christensen_bronzealderguld i boeslunde
28 kirsten christensen_bronzealderguld i boeslunde28 kirsten christensen_bronzealderguld i boeslunde
28 kirsten christensen_bronzealderguld i boeslunde
 
23 Frauke Witte, Danevirke
23 Frauke Witte, Danevirke23 Frauke Witte, Danevirke
23 Frauke Witte, Danevirke
 
Future Markets
Future MarketsFuture Markets
Future Markets
 
SugarCRM Project Management Enhancements
SugarCRM Project Management EnhancementsSugarCRM Project Management Enhancements
SugarCRM Project Management Enhancements
 
Anja Vegeberg Jensen - skovby nygård
Anja Vegeberg Jensen -  skovby nygårdAnja Vegeberg Jensen -  skovby nygård
Anja Vegeberg Jensen - skovby nygård
 

Similar a Federal tobacco control

Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Lynne Mahaffey
 
Tobacco health512
Tobacco health512Tobacco health512
Tobacco health512kguy2know
 
NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation Julmiste35
 
Tobacco cessation Therapy, India, Marketing strategy
Tobacco cessation Therapy, India, Marketing strategyTobacco cessation Therapy, India, Marketing strategy
Tobacco cessation Therapy, India, Marketing strategyRaunica Baweja
 
ALCOHOL PREVENTION GUIDELINES FINDINGS
ALCOHOL PREVENTION GUIDELINES FINDINGS ALCOHOL PREVENTION GUIDELINES FINDINGS
ALCOHOL PREVENTION GUIDELINES FINDINGS Dianova
 
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...Center on Addiction
 
OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...Office of Health Economics
 
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptxPrevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptxJanetOdhiambo2
 
Smoking cessation
Smoking cessation Smoking cessation
Smoking cessation Nimra zaman
 

Similar a Federal tobacco control (20)

Accelerating the National Progress to Reduce Tobacco Use
Accelerating the National Progress to Reduce Tobacco UseAccelerating the National Progress to Reduce Tobacco Use
Accelerating the National Progress to Reduce Tobacco Use
 
Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)
 
Cr tobacco cessation
Cr tobacco cessationCr tobacco cessation
Cr tobacco cessation
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
 
Tobacco health512
Tobacco health512Tobacco health512
Tobacco health512
 
NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation NUR 512: Community Health Program Evaluation
NUR 512: Community Health Program Evaluation
 
DAT reform-2
DAT reform-2DAT reform-2
DAT reform-2
 
Tobacco Winnable Battle presentation
Tobacco Winnable Battle presentationTobacco Winnable Battle presentation
Tobacco Winnable Battle presentation
 
Tobacco cessation Therapy, India, Marketing strategy
Tobacco cessation Therapy, India, Marketing strategyTobacco cessation Therapy, India, Marketing strategy
Tobacco cessation Therapy, India, Marketing strategy
 
Tobaccoprogress2012
Tobaccoprogress2012Tobaccoprogress2012
Tobaccoprogress2012
 
ALCOHOL PREVENTION GUIDELINES FINDINGS
ALCOHOL PREVENTION GUIDELINES FINDINGS ALCOHOL PREVENTION GUIDELINES FINDINGS
ALCOHOL PREVENTION GUIDELINES FINDINGS
 
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Bu...
 
Resolve 34 Final Report
Resolve 34 Final ReportResolve 34 Final Report
Resolve 34 Final Report
 
OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...OHE Lecturing for Professional Training at International Centre of Parliament...
OHE Lecturing for Professional Training at International Centre of Parliament...
 
GASO 11.20.2014 - The Tobacco Epidemic in the 21st Century
GASO 11.20.2014 - The Tobacco Epidemic in the 21st CenturyGASO 11.20.2014 - The Tobacco Epidemic in the 21st Century
GASO 11.20.2014 - The Tobacco Epidemic in the 21st Century
 
Developing a package of high priority health interventions for Universal Heal...
Developing a package of high priority health interventions for Universal Heal...Developing a package of high priority health interventions for Universal Heal...
Developing a package of high priority health interventions for Universal Heal...
 
MPOWER Brochure
MPOWER BrochureMPOWER Brochure
MPOWER Brochure
 
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptxPrevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
 
Martin aafp state affairs
Martin aafp state affairsMartin aafp state affairs
Martin aafp state affairs
 
Smoking cessation
Smoking cessation Smoking cessation
Smoking cessation
 

Más de Brandon Williams

Cmwg contract breaches presentation
Cmwg contract breaches presentationCmwg contract breaches presentation
Cmwg contract breaches presentationBrandon Williams
 
Mar 2012 cdphe contractor performance monitoring trng
Mar 2012 cdphe contractor performance monitoring trngMar 2012 cdphe contractor performance monitoring trng
Mar 2012 cdphe contractor performance monitoring trngBrandon Williams
 
Tobacco wb webinar 6.22.12
Tobacco wb webinar 6.22.12Tobacco wb webinar 6.22.12
Tobacco wb webinar 6.22.12Brandon Williams
 
Applicant webinar tobacco cessation initiatives
Applicant webinar tobacco cessation initiativesApplicant webinar tobacco cessation initiatives
Applicant webinar tobacco cessation initiativesBrandon Williams
 
Applicant webinar ccpd final 05-29-12
Applicant webinar ccpd final 05-29-12Applicant webinar ccpd final 05-29-12
Applicant webinar ccpd final 05-29-12Brandon Williams
 
Cdphe cd presentation for ccpd 10 14 11a
Cdphe cd presentation for ccpd 10 14 11aCdphe cd presentation for ccpd 10 14 11a
Cdphe cd presentation for ccpd 10 14 11aBrandon Williams
 
Jillians slides for 12 9 11 ccpd final
Jillians slides for 12 9 11 ccpd finalJillians slides for 12 9 11 ccpd final
Jillians slides for 12 9 11 ccpd finalBrandon Williams
 
Ttfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cbTtfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cbBrandon Williams
 
Ttfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cbTtfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cbBrandon Williams
 
Colorado lgbt data scan final 10 14-11
Colorado lgbt data scan final 10 14-11Colorado lgbt data scan final 10 14-11
Colorado lgbt data scan final 10 14-11Brandon Williams
 
PSD Obesity Presentation 2011
PSD Obesity Presentation 2011PSD Obesity Presentation 2011
PSD Obesity Presentation 2011Brandon Williams
 
Epe literature review training november 28 2011 (1)
Epe literature review training november 28 2011 (1)Epe literature review training november 28 2011 (1)
Epe literature review training november 28 2011 (1)Brandon Williams
 
LGBT HOPP Strategic Plan Slides
LGBT HOPP Strategic Plan SlidesLGBT HOPP Strategic Plan Slides
LGBT HOPP Strategic Plan SlidesBrandon Williams
 
Tobacco budget update nov 2011a
Tobacco budget update nov 2011aTobacco budget update nov 2011a
Tobacco budget update nov 2011aBrandon Williams
 
Strategic plan presentation 11.16.11
Strategic plan presentation 11.16.11Strategic plan presentation 11.16.11
Strategic plan presentation 11.16.11Brandon Williams
 
Ccpd presentation 11 4 2011
Ccpd presentation 11 4 2011Ccpd presentation 11 4 2011
Ccpd presentation 11 4 2011Brandon Williams
 

Más de Brandon Williams (20)

Cmwg contract breaches presentation
Cmwg contract breaches presentationCmwg contract breaches presentation
Cmwg contract breaches presentation
 
Mar 2012 cdphe contractor performance monitoring trng
Mar 2012 cdphe contractor performance monitoring trngMar 2012 cdphe contractor performance monitoring trng
Mar 2012 cdphe contractor performance monitoring trng
 
Tobacco wb webinar 6.22.12
Tobacco wb webinar 6.22.12Tobacco wb webinar 6.22.12
Tobacco wb webinar 6.22.12
 
Cmpu orientation webinar
Cmpu orientation webinarCmpu orientation webinar
Cmpu orientation webinar
 
Applicant webinar tobacco cessation initiatives
Applicant webinar tobacco cessation initiativesApplicant webinar tobacco cessation initiatives
Applicant webinar tobacco cessation initiatives
 
Applicant webinar ccpd final 05-29-12
Applicant webinar ccpd final 05-29-12Applicant webinar ccpd final 05-29-12
Applicant webinar ccpd final 05-29-12
 
MCH Data to Action
MCH Data to ActionMCH Data to Action
MCH Data to Action
 
Tobacco wb webinar 5 1-12
Tobacco wb webinar 5 1-12Tobacco wb webinar 5 1-12
Tobacco wb webinar 5 1-12
 
Cdphe cd presentation for ccpd 10 14 11a
Cdphe cd presentation for ccpd 10 14 11aCdphe cd presentation for ccpd 10 14 11a
Cdphe cd presentation for ccpd 10 14 11a
 
Jillians slides for 12 9 11 ccpd final
Jillians slides for 12 9 11 ccpd finalJillians slides for 12 9 11 ccpd final
Jillians slides for 12 9 11 ccpd final
 
Ttfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cbTtfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cb
 
Ttfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cbTtfcci mid program presentation to trc 121411.cb
Ttfcci mid program presentation to trc 121411.cb
 
Colorado lgbt data scan final 10 14-11
Colorado lgbt data scan final 10 14-11Colorado lgbt data scan final 10 14-11
Colorado lgbt data scan final 10 14-11
 
PSD Obesity Presentation 2011
PSD Obesity Presentation 2011PSD Obesity Presentation 2011
PSD Obesity Presentation 2011
 
Epe literature review training november 28 2011 (1)
Epe literature review training november 28 2011 (1)Epe literature review training november 28 2011 (1)
Epe literature review training november 28 2011 (1)
 
Colorado leadership v4
Colorado leadership v4Colorado leadership v4
Colorado leadership v4
 
LGBT HOPP Strategic Plan Slides
LGBT HOPP Strategic Plan SlidesLGBT HOPP Strategic Plan Slides
LGBT HOPP Strategic Plan Slides
 
Tobacco budget update nov 2011a
Tobacco budget update nov 2011aTobacco budget update nov 2011a
Tobacco budget update nov 2011a
 
Strategic plan presentation 11.16.11
Strategic plan presentation 11.16.11Strategic plan presentation 11.16.11
Strategic plan presentation 11.16.11
 
Ccpd presentation 11 4 2011
Ccpd presentation 11 4 2011Ccpd presentation 11 4 2011
Ccpd presentation 11 4 2011
 

Último

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 

Último (20)

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 

Federal tobacco control

  • 1. Tobacco Control & Prevention National Update Presented to Tobacco Program Grant Review Committee Dec. 16, 2011
  • 2. Major Initiatives • Centers for Disease Control and Prevention –Office on Smoking & Health • U.S. Food & Drug Administration (FDA) • National Tobacco Control Strategy • Health Care Reform
  • 3. CDC – Office on Smoking & Health • “Accelerating the Decline” initiative – Perception problem is solved, lack of advocacy partners, 18-24 yrs. & low SES still high, better use FDA authority. • Upcoming Surgeon General’s Report on Youth Tobacco Use – (Spring 2012) • First ever national media campaign – Spring of 2012, hard hitting, 1-800 Quitline number • Less than .02 per dollar of revenue going towards programs – big reductions in states • Federal funding cuts, OSH competitive grant?
  • 4. U.S. Food and Drug Administration • Granted Regulatory Authority over tobacco products (6/09) • Restricts Marketing and Sales to Youth • Requires Disclosure of Ingredients • Regulates “reduces harm” claims (no more light, mild, or low-tar) • Bigger, bolder health warnings on packages • Requires industry to pay user fee to FDA to support efforts ($800M/yr)
  • 5. U.S. Food and Drug Administration • Authority to further restrict marketing • Allows FDA to require changes in the product (cannot ban nicotine completely) • Created the Tobacco Products Scientific Advisory Committee (TPSAC) – Recommended removal of menthol cigarettes from the market) – Working on dissolvable tobacco products (3/12)
  • 6. U.S. Food and Drug Administration • Industry preventing progress by: –Suing over warning labels –Suing over Menthol report – Increasing marketing and sales of dissolvable tobacco products –Suing some more about anything
  • 7. National Tobacco Prevention and Control Strategy • First of its kind comprehensive national plan • “Ending the Tobacco Epidemic” –Released by HHS – Nov. 2010 • Focused on Evidenced- based strategies • Includes national media campaign • Requires all HHS campuses are tobacco free • Required Medicare and Medicaid to include tobacco cessation services • Includes more funding for research
  • 8. Health Care Reform • New Coverage Under Medicaid – Oct. 1, 2010 – state Medicaid programs must provide a comprehensive cessation benefit with no-cost sharing/co-pay & requires expanded private insurance coverage of cessation/treatment without cost sharing – Jan. 1, 2013 – increased federal reimbursements for cessation – Jan 1, 2014 – state Medicaid programs cannot exclude smoking cessation drugs form their prescription drug coverage
  • 9. Health Care Reform • Creation of Public Health Prevention Fund to support proven prevention, wellness and public health programs in communities – Community Transformation Grants that include additional funding for tobacco programs & QuitLines – Possible 68% cut to offset impact of continued payroll tax deductions (changes by the day)
  • 10. Key Opportunities • National media campaign with quit smoking call to action & QuitLine # (spring 2012) • Warning labels with QuitLine # (fall 2013) • Banning of Menthol ?? • Release of Surgeon Generals report on Youth Tobacco Use (Spring 2012) • Insurance Reimbursement for cessation services and counseling • FDA – needs for input, testimony from states
  • 11. Key Threats • Modified Risk Products • Dissolvable Tobacco Products • Stall in decreases of adult prevalence • Increases in use among 18-24 year olds • Competitive applications for CDC funds • Tobacco issues is solved – obesity is the problem • Low SES smokers – how to get them to quit
  • 12. Always the Question • DOES SPENDING MORE ON TOBACCO CONTROL PROGRAMS MAKE ECONOMIC SENSE?
  • 13. AN INCREMENTAL BENEFIT-COST ANALYSIS USING PANEL DATA Journal of Contemporary Economic Policy, Nov. 27. 2011 • This paper presents a benefit-cost analysis of the ongoing, state-level tobacco prevention and control programs in the United States. Using state-level panel data for the years 1991–2007, the study applies several variants of econometric modeling approaches to estimate the state- level tobacco demand. The paper finds a statistically significant evidence of a sustained and steadily increasing long-run impact of the tobacco control program spending on cigarette demand in states. The study also shows that, if individual states follow the Best Practices funding guidelines, potential future annual benefits of the tobacco control program can be as high as 14–20 times the cost of program implementation. (JEL C2, H5, I1)